| ELANCO ANIMAL HEALTH. |
| USA |
| Gesundheit |
| US28414H1032 / A2N6BH |
| 5EA (Frankfurt) / ELAN (NYSE) |
| FRA:5EA, ETR:5EA, 5EA:GR, NYSE:ELAN |
| - |
| https://www.elanco.com/ |
|
Elanco Animal Health Incorporated is a leading global pharmaceutical company specializing in animal health. Its primary function is the development and delivery of innovative products and solutions to prevent and treat diseases in both companion anim..
>Volltext.. |
| 8963.31 Mio. EUR |
| 12048.53 Mio. EUR |
| 4211.59 Mio. EUR |
| 852.99 Mio. EUR |
| -208.3 Mio. EUR |
| -0.42 EUR |
| 3435.2 Mio. EUR |
| 368.4 Mio. EUR |
| - |
| 0.26 |
| 3.49% |
| -160.75% |
| - |
| - |
| - |
| ELANCO |
| 22.05.26 |